Drug Development Research

Title Publication Date Language Citations
Curcumin reduces inflammation in knee osteoarthritis rats through blocking TLR4 /MyD88/NF‐κB signal pathway2019/01/21English70
The protective effect of kaempferol on heart via the regulation of Nrf2, NF‐κβ, and PI3K/Akt/GSK‐3β signaling pathways in isoproterenol‐induced heart failure in diabetic rats2019/03/12English69
Distribution of GABAA and GABAB receptors in mammalian brain: Potential targets for drug development1990/01/01English69
Purinoceptor nomenclature: A status report1993/03/01English68
Neurochemical mechanisms mediating the behavioral and cognitive effects of nicotine1994/01/01English68
Haemodynamic effects in man during exercise of a single oral dose of narbivolol (R 67555), a new beta‐1‐adrenoceptor blocking agent: A comparative study with atenolol, pindolol, and propranolol1986/05/01English65
The clinical pharmacology of therapeutic monoclonal antibodies2004/03/01English65
The potential of siRNA based drug delivery in respiratory disorders: Recent advances and progress2019/07/16English65
Bedaquiline and delamanid in the treatment of multidrug‐resistant tuberculosis: Promising but challenging2018/12/11English65
5‐HT6 antagonists as potential treatment for cognitive dysfunction2009/03/01English65
Novel aminopropiophenones as potential antidepressants2003/11/12English64
Can light‐based approaches overcome antimicrobial resistance?2018/08/02English63
Activation of Nrf2 signaling by sitagliptin and quercetin combination against β‐amyloid induced Alzheimer's disease in rats2019/07/13English62
Pharmacological properties of dolasetron, a potent and selective antagonist at 5‐HT3 receptors1993/01/01English62
Telmisartan as tentative angiotensin receptor blocker therapeutic for COVID‐192020/05/01English62
Progress toward the development of a viable BACE‐1 inhibitor2009/03/01English61
Effects of anabaseine‐related analogs on rat brain nicotinic receptor binding and on avoidance behaviors1994/02/01English61
Pharmacological profile of ritanserin: A very specific central serotonin S2‐antagonist1988/01/01English61
ATP‐sensitive K+ channels: Pharmacologic properties, regulation, and therapeutic potential1993/02/01English61
DuP 996 (3,3‐bis(4‐pyrindinylmethyl)‐1‐phenylindolin‐2‐one) enhances the stimulus‐induced release of acetylcholine from rat brain in vitro and in vivo1990/01/01English61
Inhibition of ultrasonic distress vocalizations in rat pups by chlordiazepoxide and diazepam1985/01/01English60
Changing concepts of the biochemical action of the anxioselective drug, buspirone1984/01/01English60
Computational Approaches for Drug Discovery2014/09/01English59
Cytochrome p‐450: Target for itraconazole1986/05/01English59
Medical drugs from humus matter: Focus on mumie2002/11/01English59
Discrete thermally responsive hydrogel‐coated gold nanoparticles for use as drug‐delivery vehicles2006/01/01English58
Role of GSK‐3β in Alzheimer's disease pathology2002/07/01English58
Recent Developments of Hydrazide/Hydrazone Derivatives and Their Analogs as Anticonvulsant Agents in Animal Models2016/10/24English57
A new model to assess analgesic activity: Pain‐induced functional impairment in the rat (PIFIR)1993/02/01English56
Interaction of nocodazole with tubulin isotypes2002/02/01English56